pharma · Stargardt Disease · Muscle Relaxation · ELTP
ELITE PHARMACEUTICALS INC
ELITE PHARMACEUTICALS INC /NV/
ELITE PHARMACEUTICALS INC trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Northvale, USA
- Founded
- 1996
- Employees
- 64
- Programs
- 8
- Drugs
- 24
- Patents
- 26
ELITE PHARMACEUTICALS INC clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to ELITE PHARMACEUTICALS INC programs — each row shows trial ID, program name, phase, status, and indication.
ELITE PHARMACEUTICALS INC trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for ELITE PHARMACEUTICALS INC.
-
LBS-008-CT05 — Phase 3
Clinical update -
Rocuronium — Approved
Clinical update -
Rocuronium Bromide — Approved
Clinical update -
Oxycodone/Naltrexone Capsules — Phase 3
Clinical update -
Oxycodone Naltrexone (a) — Phase 3
Clinical update -
Tinlarebant 5 mg´s matching Placebo, LBS-008 — Phase 3
Clinical update -
LBS-008 — Phase 3
Clinical update -
GSK2330672 — Phase 2
Clinical update